Pre Seed · Medtech & Devices · Barcelona, Spain · Founded 2023 · 2–10 employees
Banting Labs is developing a non‑invasive, real‑time multisensor to monitor blood glucose and other biomarkers without finger pricks, targeting people with type 1 diabetes and broader wellness users. The company grew out of the university project 'Hoop Diabetes' and is incubated at TecnoCampus, with a multidisciplinary founding team that includes clinical and engineering leadership. Banting Labs received a €100,000 Startup Capital grant from ACCIÓ in July 2024 to fund initial product development and validation and has been active in events such as MWC/4YFN to raise visibility. The device is still in development and not authorized for sale, placing the company in an early pre‑market medtech stage with clinical oversight and institutional support.
No open roles listed right now.